Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
In recent years, immune checkpoint inhibitors (ICIs) have emerged as a transformative approach in treating advanced hepatocellular carcinoma (HCC). Despite their success, challenges persist, including concerns about their effectiveness, treatment costs, frequent occurrence of treatment-related adver...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Sprog: | English |
| Udgivet: |
Frontiers Media S.A.
2023-12-01
|
| Serier: | Frontiers in Immunology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1326097/full |